SCHEMBL7424550

SCHEMBL7424550

CCCc1[nH]c2cc(C(=O)O)cc(Cc3ccccc3Cl)c2c1C(=O)Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
ALOX15 P16050 1/20 0.37
ALDH1A1 P00352 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
IDO1 P14902 1/20 0.35
SNCA P37840 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
GRIN1 Q05586 1/20 0.34
PTGES O14684 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL251645 0.88 ALOX5 (0.43) ALOX5LMNASMN1; SMN2RAB9AALDH1A1
SCHEMBL8555747 0.83 PLK1 (0.39) ALOX5LMNASMN1; SMN2PDE3BPDE3A
SCHEMBL8554409 0.80 LMNA (0.47) ALOX5LMNASMN1; SMN2PDE3BPDE3A
SCHEMBL7707823 0.79 ALOX5 (0.44) ALOX5LMNASMN1; SMN2GAARAB9A
SCHEMBL8555588 0.79 SMN1; SMN2 (0.47) ALOX5LMNASMN1; SMN2ALDH1A1PDE3B
SCHEMBL8551585 0.78 SMN1; SMN2 (0.48) ALOX5LMNASMN1; SMN2ALDH1A1PDE3B
SCHEMBL8554263 0.77 ALOX5 (0.39) ALOX5LMNASMN1; SMN2ALDH1A1PDE3B
SCHEMBL6930961 0.77 ALOX5 (0.39) ALOX5LMNASMN1; SMN2ALDH1A1PDE3B
SCHEMBL8551861 0.77 ALOX5 (0.41) ALOX5LMNASMN1; SMN2ALDH1A1PDE3B
SCHEMBL8557456 0.75 LMNA (0.48) ALOX5LMNASMN1; SMN2RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed